Related Experiment Video
Updated: Jul 18, 2025

Author Spotlight: Dermatopathology and the Treatment of Sexually Transmitted Diseases
Published on: November 8, 2024
Vulvar Lichen Sclerosus Et Atrophicus: Refractory to Standard Therapy
Thasneem S Luqman1, Akshay Kalavant2, K S Sunil Kumar3
1Department of Emergency Medicine, Trivandrum Medical College, Thiruvananthapuram, Kerala, India.
Insights
Vulvar lichen sclerosus et atrophicus (LS) is a rare inflammatory condition in children. Topical tacrolimus effectively treated a prepubertal case resistant to clobetasol, offering a new therapeutic option.
Area of Science:
- Dermatology
- Pediatrics
- Gynecology
Background:
- Vulvar lichen sclerosus et atrophicus (LS) is an inflammatory dermatosis with potential pediatric involvement, though often underdiagnosed.
- LS can present with genital and extragenital symptoms, potentially leading to significant quality of life impairment if untreated.
Observation:
- A rare case of prepubertal vulvar LS is presented.
- The condition was refractory to the standard first-line treatment, topical clobetasol propionate.
Findings:
- The vulvar LS in this pediatric patient responded successfully to topical tacrolimus.
- This suggests tacrolimus as a viable alternative treatment for refractory cases.
Implications:
- Topical tacrolimus may be an effective alternative for pediatric vulvar LS unresponsive to topical corticosteroids.
- Further research into non-steroidal options for pediatric LS is warranted to improve patient outcomes.
Abstract:
Vulvar lichen sclerosus et atrophicus is an inflammatory disease which can affect the pediatric age group, although rarely. Its prevalence is underestimated. It may have genital or extragenital manifestations. If left untreated, it may progress to complications which hamper the quality of life. The treatment of choice is topical clobetasol propionate. Here, we present a case of prepubertal vulvar LS, which was refractory to topical clobetasol but responded to topical tacrolimus application.
Related Concept Videos
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Treatment Resistant Cancers
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Rheumatic Heart Disease III: Medical Management

